FDA Approves Biogen Alzheimer’s Drug For First Time In 18 Years

The Food and Drug Administration approved a new treatment drug for Alzheimers, the first the agency has approved since 2003, causing controversy with experts that are hesitant on the effectiveness of the drug. 
» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://apps.nbcnews.com/mobile
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Follow NBC News on Instagram: http://nbcnews.to/InstaNBC

#FDA #Alzheimers #NBCNews

source

Author: avnblogfeed

ANGELHOUSE © 2009 - 2022 | HOSTING BY PHILLYFINEST369 SERVER STATS| & THE IDIOTS ROBOT AND CONTROL INC. |(RSS FEED MODULE)| ALL YOUTUBE VIDEOS IS A REGISTERED TRADEMARK OF GOOGLE INC. THE YOUTUBE CHANNELS AND BLOG FEEDS IS MANAGED BY THERE RIGHTFUL OWNERS (AVNBLOGFEED.COM)

24 thoughts on “FDA Approves Biogen Alzheimer’s Drug For First Time In 18 Years

  1. So lets see there are hundreds of drugs and procedures in the UK that work but can't get approval in the US and we can't seem to fast track life extension research but we can approve a highly questionable drug that will mostly likely live off of Medicare payments. The FDA is an nothing but a corporate stooge designed to keep out competitors and keep prices high.

  2. One of the trial actually worsened the disease while the other had a marginal effect that is medically meaningless.
    FAD acknowlege that there was no observed benefit but was approved on the basis that it was able to remove beta amyloid which should likely result in future benefit.
    However a paper in 2019 titled " persistent neurological effects 14 years gollowing amyloid- b immunization in Alzheimer's disease" whose research tracked the following 14 years after a group of patients whose same beta amyloid proteins were remove by a vaccine AN1792 , found no benefit nor slow down in progression till death of the patients
    FDA must know this report but chose to ignore it.

  3. That's great to hear, this can help other families, today my grandmother was buried, she had alzheimers for almost 20 yrs. She lived 96 yrs. She didn't know us anymore, but we were glad to still have her alive. So glad to hear there's a bit of hope.

  4. Whether it's approved or not depends more on who's make the profit and who's getting paid not if it actually works. This is just the way it is today, it's all about the money!

Comments are closed.